Results 261 to 270 of about 180,427 (290)
Some of the next articles are maybe not open access.
Diffuse Large B-Cell Lymphomas
2010De novo diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma worldwide, accounting for approximately 30–40% of adult non-Hodgkin lymphomas. It is defined as a diffuse proliferation of large neoplastic B lymphoid cells with a nuclear size equal to or exceeding that of a normal macrophage or more than twice the size of a normal lymphocyte ...
openaire +2 more sources
Endobronchial Diffuse Large B-cell Lymphoma
Archivos de Bronconeumología (English Edition), 2020Masahiro, Yamasaki +2 more
openaire +2 more sources
2001
INTRODUCTION Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL), accounting for 35–40% of all cases of NHL. Despite high reported response rates to anthracycline-based combination chemotherapy regimens, only 50–65% of patients with this disease have achieved long-term disease-free survival with this approach.
John W. Sweetenham +3 more
openaire +1 more source
INTRODUCTION Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma (NHL), accounting for 35–40% of all cases of NHL. Despite high reported response rates to anthracycline-based combination chemotherapy regimens, only 50–65% of patients with this disease have achieved long-term disease-free survival with this approach.
John W. Sweetenham +3 more
openaire +1 more source
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
Cancer Cell, 2021Chloé B Steen +2 more
exaly
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
New England Journal of Medicine, 2022Hervé Tilly +2 more
exaly
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
New England Journal of Medicine, 2022Michael Dickinson +2 more
exaly
Improving Outcomes for Patients With Diffuse Large B-Cell Lymphoma
Ca-A Cancer Journal for Clinicians, 2010Christopher R Flowers, Julie M Vose
exaly